🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1 open-label, multicenter study to investigate tolerability...
Status
Active Not Recruiting
Location
Providence Saint John's Cancer Institute
Start Date
2023-04-17
Trial ID
NCT05561374
Treatments Being Tested
To provide OKN-007 for compassionate use in patients with diffuse midline g...
Status
No Longer Available
Location
Arkansas Children's Research Institute
Start Date
TBD
Trial ID
NCT05518838
Treatments Being Tested
This is a phase II open-label study investigating the efficacy, safety and ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04388475
Treatments Being Tested
This is an open label Phase 1b clinical trial of IV administration of OKN-0...
Status
Unknown
Location
Oklahoma University
Start Date
2012-12
Trial ID
NCT01672463
Treatments Being Tested
The objective of this study is to investigate tolerability, safety, pharmac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT03649464
Treatments Being Tested
This is a pilot study exploring the potential benefit of adding OKN-007 wit...
Status
Active Not Recruiting
Location
Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Start Date
2018-09-03
Trial ID
NCT03587038
Treatments Being Tested